Polyphosphoric acid capping radioactive/upconverting NaLuF4:Yb,Tm,Sm-153 nanoparticles for blood pool imaging in vivo
Polyphosphoric acid capping radioactive/upconverting NaLuF4:Yb,Tm,Sm-153 nanoparticles for blood pool imaging in vivo
复制标题
用于体内血池成像的多磷酸封端放射性/上转换NaLuF4:Yb,Tm,Sm-153纳米粒子
DOI:
10.1016/j.biomaterials.2013.07.098
复制
发表时间:
2013
期刊:
影响因子:
14
通讯作者:
Li Fuyou
中科院分区:
文献类型:
--
作者:
Peng Juanjuan;Sun Yun;Zhao Lingzhi;Wu Yongquan;Feng Wei;Gao Yanhong;Li Fuyou
Nanoparticles that circulate in the bloodstream for a prolonged period of time have important biomedicine applications. However, no example of lanthanide-based nanoparticles having a long-term circulation bloodstream has been reported to date. Herein, we report on difunctional radioactive and upconversion nanoparticles (UCNP) coated with polyphosphoric acid ligand, that is ethylenediamine tetramethylenephosphonic acid (EDTMP), for an application in single-photon emission computed tomography (SPECT) blood pool imaging. The structure, size and zeta-potential of the EDTMP-coated nanoparticles (EDTMP-UCNP) are verified using transmission electron microscopy and dynamic light scattering. Injection of radioisotope samarium-153-labeled EDTMP-UCNP (EDTMP-UCNP:153Sm) into mice reveal superior circulation time compared to control nanoparticles coated with citric acid (cit-UCNP:153Sm) and153Sm complex of EDTMP (EDTMP-153Sm). The mechanism for the extended circulation time may be attributed to the adhesion of EDTMP-UCNP on the membrane of red blood cells (RBCs).In vivotoxicity results show no toxicity of EDTMP-UCNP at the dose of 100 mg/kg, validating its safety as an agent for blood pool imaging. Our results provide a new strategy of nanoprobe for a long-term circulation bloodstream by introducing polyphosphoric acid as surface ligand.